Concepedia

AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge

Matthew M. Guilleman, Brenna A. Y. Stevens, Laura P. van Lieshout, Amira D. Rghei, Yanlong Pei, Lisa A. Santry, Brad Thompson, Sarah K. Wootton

Gene Therapy · 2021 · 13 citations · 24 references

DOI

Concepts

References

24

Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection

Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo et al. · Molecular Therapy · 2008 · 1.5K citations · Full text

, , +15

Glucosylation of Rho proteins by Clostridium difficile toxin B

Ingo Just, Jörg Selzer, Matthias Wilm et al. · Nature · 1995 · 1K citations

, , +14

Trends in U.S. Burden of <i>Clostridioides difficile</i> Infection and Outcomes

Alice Guh, Yi Mu, Lisa G. Winston et al. · New England Journal of Medicine · 2020 · 840 citations · Full text

, , +12

Antibody-based protection against HIV infection by vectored immunoprophylaxis

Alejandro B. Balazs, Joyce Chen, Christin M. Hong et al. · Nature · 2011 · 549 citations

, , +16

The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins

Ingo Just, Matthias Wilm, Jörg Selzer et al. · Journal of Biological Chemistry · 1995 · 480 citations · Full text

, , +15